Survival after sorafenib: expect the unexpected.
Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at UCLA, Los Angeles, CA, United States. Electronic address: rfinn@mednet.ucla.edu.
Richard S
RS
Finn
D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male